Busca
« ant |
1 - 50 de 65
|
próx »
Resultados da Busca
Select an image to start the slideshow
Spatial patterns of extensively drug-resistant tuberculosis and associations with sociodemographic factors in Durban, South Africa
1 of 50
Factors Associated with Unexpectedly Long Prescribed Therapy for Tuberculosis Patients Eligible for Short-Course Therapy in the United States, 2009 – 2016
2 of 50
Factors Associated with Ototoxicity among TB Patients Treated with Aminoglycosides
3 of 50
Tuberculosis among Healthcare Workers, United States, 2010-2016
4 of 50
Enhancing Tuberculosis Case Finding among HIV-Infected Patients in Ethiopia
5 of 50
Social and behavioral factors predicting beliefs about the use of traditional Chinese medicine for tuberculosis treatment in Myanmar and Yunnan, China.
6 of 50
The Burden of Tuberculosis Among Acute Emergency-Affected Displaced Populations
7 of 50
Trends in mortality, length of stay, and inpatient charges among tuberculosis hospitalizations with and without coexisting diabetes, US, 2000 - 2011
8 of 50
Factors that Influence the Prevalence of Latent Tuberculosis Infection among Healthcare Workers in Thailand
9 of 50
The Effect of Immune Status on the Performance of a WHO-recommended
Screening Tool for Tuberculosis in HIV-infected Patients in
South-East Asia
10 of 50
Nutritional and Metabolic Profiling of Pulmonary Tuberculosis
11 of 50
Distribution and Determinants of Tuberculosis, Kingdom of Saudi Arabia, 2005- 2012
12 of 50
Faith-based Social Capital, Racial Trust, Community Support of
Immigrants' Rights and Risk of Tuberculosis in Selected
Metropolitan Statistical Areas, 2000 and 2006.
13 of 50
Epidemiology of Tuberculosis and Evaluation of Treatment Delay
Among Foreign-Born Hispanic Persons in the United States
14 of 50
Patient adherence to Directly Observed Therapy (DOT) for
Tuberculosis in a rural community in Gujarat, India.
15 of 50
Grant Proposal for Tuberculosis Prevention through an Examination of Migration Patterns in Mexico, within the Border State of Tamaulipas
16 of 50
RIFAMYCIN-RESISTANT TUBERCULOSIS IN THE UNITED STATES,
1998-2008; an Analysis of the National Tuberculosis
Surveillance System
17 of 50
Assessing specificity and discordance between the tuberculin
skin test and a whole-blood interferon-γ release assay for the
detection of Mycobacterium tuberculosis infection
among United States Navy recruits.
18 of 50
Utilizing genotypic mutations to determine treatment effectiveness among MDR and XDR TB patients in KwaZulu-Natal, SouthAfrica
19 of 50
The Role of Exogenous Reinfection in Patients with Recurrent TB
Disease in the United States
20 of 50
Tuberculosis Prevalence Among Entrants and Stock Population in a
Haitian Prison: A Quality Assessment of Screening Procedures
21 of 50
Risk factors for active and latent tuberculosis (TB) among contacts
of smear-positive index TB patients in the country of Georgia
22 of 50
Change in Chest Radiography and Examination of Clinical Features to
Identify Pulmonary Tuberculosis in a Haitian Prison
23 of 50
A Comparative Analysis in the Annual Rate of Change in US-born
Non-Hispanic Black and US-born Non-Hispanic White Tuberculosis
Cases, 1993-2011
24 of 50
Diabetes mellitus and active tuberculosis disease: Clinical
presentation and treatment outcomes in adult tuberculosis patients
25 of 50
Agreement between Tuberculin Skin Test (TST) and QuantiFERON-TB
Gold In-Tube (QFT) Assay When Screening for Latent Tuberculosis
Infection (LTBI) in Young Refugee Children
26 of 50
THE OCCURRENCE OF CLINICALLY ACTIVE TUBERCULOSIS AMONG HIV-INFECTED
PERSONS IN MUMBAI, INDIA.
27 of 50
Multi-drug Resistant (MDR) and Extensively Drug Resistant (XDR)
Tuberculosis Case Study Book Project
28 of 50
Does Level of Access to Tuberculosis (TB) Treatment Predict Default
Patterns? A multilevel analysis.
29 of 50
Evaluation of Tuberculosis Public Health Surveillance,Al-Madinah Province, Kingdom of Saudi Arabia, 2012
30 of 50
Examination of Optimal Culture Methodologies and Conditions for
Tuberculosis Treatment Trials
31 of 50
Plasma Metabolomics in the Diagnosis of Pulmonary Tuberculosis and
Early Identification of Multidrug Resistance
32 of 50
Influences of the Homeless Shelter Environment on the
Personal Experience of Tuberculosis Disease During a Large Outbreak
in Atlanta, Georgia
33 of 50
Cox Proportional Hazards Analysis to
Determine the Predictors of Time-to-Sputum Culture Conversion in
Patients with Tuberculosis
34 of 50
Tuberculosis Screening Among Immigrants Entering the United States:
An Analysis of Radiographic Findings of China, Mexico, Nepal,
Philippines and Vietnam
35 of 50
Characterization of tuberculosis (TB) in Lebanon: epidemiology and
risk factors for extrapulmonary TB
36 of 50
Cost Savings Associated with Implementation of the MTBDRplus
Assay in the Republic of Georgia
37 of 50
Impact of Active Case-Finding on Tuberculosis Transmission Among
the Homeless in Fulton County, Georgia, 2010-2015: Secondary Data
Analysis
38 of 50
Prevalence and Risk Factors of TB Disease in South African
Correctional Facilities
39 of 50
Tumor Necrosis Factor-Antagonist Therapy Exposure Associated with
Sputum Conversion by Eight Weeks among United States Tuberculosis
Patients, 2010-2015
40 of 50
Impact of Mobile Teams on Tuberculosis Treatment Outcomes,
Ministry of Health, Riyadh Region, Kingdom of Saudi Arabia, 2013 -
2015
41 of 50
Survival Analysis Comparing HIV Infection Status and Time until
Diagnosis in Tuberculosis Cases in the United States Foreign-Born
Population by Region of Origin, 2005-2015
42 of 50
HIV and Tuberculosis in Atlanta, GA: Antiretroviral Therapy Uptake
and Factors Associated with Unfavorable Outcomes
43 of 50
A county-level, ecologic analysis of correlations between recent tuberculosis transmission and socioeconomic indicators of poverty.
44 of 50
Delays to TB care among Zambian mineworkers: Application of the Three-Delay Framework
45 of 50
Influence of HIV Co-infection on Tuberculosis Treatment Outcomes in Children: A Systematic Review and Meta-analysis of the Literature
46 of 50
Incidence and Prediction of Symptoms and Drug Sensitivity Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) for Treatment of Latent Tuberculosis Infection
47 of 50
Diagnosis and Prevention of Active TB Disease
48 of 50
CD4 T Cell Responses in Mycobacterium tuberculosis and HIV Co-infection
49 of 50
T cell immunity during co-infection with Mycobacterium tuberculosis and Schistosoma mansoni
50 of 50